| scholarly article | Q13442814 |
| P50 | author | Margherita Doria | Q40745487 |
| Mario Mondelli | Q56480714 | ||
| P2093 | author name string | Caroline Molette | |
| Daniele Accapezzato | |||
| Maria Rosaria Torrisi | |||
| Marino Paroli | |||
| Tiziana Donato | |||
| Vincenzo Barnaba | |||
| Vincenzo Visco | |||
| Vittorio Francavilla | |||
| P2860 | cites work | Antigen presentation and T cell stimulation by dendritic cells | Q22255632 |
| Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells | Q24653129 | ||
| Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
| Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody | Q27485923 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| A human homologue of the Drosophila Toll protein signals activation of adaptive immunity | Q28131769 | ||
| Of mice and not men: differences between mouse and human immunology | Q28246229 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells | Q28506676 | ||
| Phagosomes are competent organelles for antigen cross-presentation | Q28591811 | ||
| Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes | Q28609747 | ||
| Visualizing dendritic cell networks in vivo | Q29616233 | ||
| Dendritic cells: specialized and regulated antigen processing machines | Q29617085 | ||
| Tolerogenic dendritic cells | Q29618755 | ||
| Molecular identification of a danger signal that alerts the immune system to dying cells | Q29619497 | ||
| Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines | Q33683185 | ||
| Natural adjuvants: endogenous activators of dendritic cells | Q33878894 | ||
| Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay | Q33903838 | ||
| Cross-presentation, dendritic cells, tolerance and immunity | Q34178099 | ||
| Antigen bias in T cell cross-priming | Q34323408 | ||
| A new foreign policy: MHC class I molecules monitor the outside world | Q34398620 | ||
| Kinetics of intracellular transport and sorting of lysosomal membrane and plasma membrane proteins | Q36217696 | ||
| Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells | Q36274042 | ||
| Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells | Q36275163 | ||
| Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages | Q36327656 | ||
| Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli | Q36350548 | ||
| Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins | Q36352027 | ||
| Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen | Q36355057 | ||
| Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming | Q80975562 | ||
| Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis | Q36365348 | ||
| Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization | Q36367948 | ||
| The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo | Q36370304 | ||
| Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells | Q36375909 | ||
| Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance | Q36376611 | ||
| Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism | Q36380421 | ||
| Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells | Q36401207 | ||
| Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways | Q36404658 | ||
| CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression | Q36538938 | ||
| Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens | Q36689895 | ||
| Cellular protein is the source of cross-priming antigen in vivo | Q36853548 | ||
| Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. | Q37424192 | ||
| Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. | Q40481734 | ||
| CD8+ T cell cross-priming via transfer of proteasome substrates | Q40551130 | ||
| Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells | Q40555227 | ||
| Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming | Q40795464 | ||
| Purified influenza virus nucleoprotein protects mice from lethal infection | Q40799908 | ||
| Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 | ||
| Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules | Q41120866 | ||
| Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. | Q41262004 | ||
| A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules | Q41380874 | ||
| Capture and processing of exogenous antigens for presentation on MHC molecules. | Q41464375 | ||
| Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus | Q41483433 | ||
| Presentation of exogenous antigen with class I major histocompatibility complex molecules | Q41724565 | ||
| Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes | Q41733978 | ||
| Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo | Q41872431 | ||
| Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. | Q41915692 | ||
| Chloroquine reduces whole body proteolysis in humans | Q41934971 | ||
| Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms | Q42982934 | ||
| Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease | Q44285977 | ||
| Antigen recognition. Class discrimination in the world of immunology | Q44582156 | ||
| Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain | Q44623197 | ||
| Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate | Q45345585 | ||
| Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages | Q45345587 | ||
| Toll-like receptor 3 promotes cross-priming to virus-infected cells. | Q45511446 | ||
| Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo | Q45776645 | ||
| Flow analysis of MHC molecules and other membrane proteins in isolated phagosomes | Q47815880 | ||
| Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules | Q50146397 | ||
| Phagocytic processing of bacterial antigens for class I MHC presentation to T cells | Q50167043 | ||
| Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells | Q50335818 | ||
| Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells | Q50335820 | ||
| Enhanced Dendritic Cell Antigen Capture via Toll-Like Receptor-Induced Actin Remodeling | Q57204114 | ||
| Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity | Q58862024 | ||
| Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression | Q67687100 | ||
| Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells | Q67902824 | ||
| Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes | Q69073408 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chloroquine | Q422438 |
| P304 | page(s) | 817-28 | |
| P577 | publication date | 2005-09-19 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo | |
| P478 | volume | 202 |
| Q35941274 | A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8(+) T cell responses |
| Q37903403 | A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. |
| Q58799522 | A novel probe to assess cytosolic entry of exogenous proteins |
| Q28475036 | A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults |
| Q40251233 | Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling |
| Q38620773 | Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines |
| Q35927584 | Antigen Cross-Priming of Cell-Associated Proteins is Enhanced by Macroautophagy within the Antigen Donor Cell. |
| Q36822696 | Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation |
| Q33646495 | Antigen release kinetics in the phagosome are critical to cross-presentation efficiency |
| Q36238593 | Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation |
| Q92757487 | Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences |
| Q35913715 | CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease |
| Q38405361 | Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens |
| Q33617999 | Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model |
| Q34400527 | Combinatorial contextualization of peptidic epitopes for enhanced cellular immunity |
| Q26799991 | Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets |
| Q38025870 | Cross-presentation by dendritic cells |
| Q91855281 | Cross-presentation of Exogenous Antigens |
| Q53515355 | Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection. |
| Q59355662 | Current Concepts of Antigen Cross-Presentation |
| Q24682603 | DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes |
| Q90161713 | Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting |
| Q38218671 | Dendritic cell-targeted vaccines |
| Q36939901 | Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting |
| Q37744071 | Designing CD8+ T cell vaccines: it's not rocket science (yet). |
| Q38821711 | Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets |
| Q35024484 | Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells |
| Q38911753 | Dying cells actively regulate adaptive immune responses |
| Q47253016 | Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing |
| Q33300327 | Endocytosis of DNA-Hsp65 alters the pH of the late endosome/lysosome and interferes with antigen presentation |
| Q37638201 | Endolysosomal proteases and their inhibitors in immunity. |
| Q89762172 | Endoplasmic Reticulum-Associated Degradation-Dependent Processing in Cross-Presentation and Its Potential for Dendritic Cell Vaccinations: A Review |
| Q41926871 | Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo |
| Q36228836 | Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis |
| Q37067893 | Fungal vaccines: real progress from real challenges |
| Q40460817 | Generation of Immunity against Pathogens via Single-Domain Antibody-Antigen Constructs. |
| Q35960524 | Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3. |
| Q37776772 | Hepatitis C virus infection: A “liaison a trois” amongst the virus, the host, and chronic low-level inflammation for human survival |
| Q96110894 | Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? |
| Q37854742 | Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy |
| Q58960918 | IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens |
| Q37643349 | Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine |
| Q34513978 | Improved antigen cross-presentation by polyethyleneimine-based nanoparticles |
| Q39177220 | Influence of protein fold stability on immunogenicity and its implications for vaccine design |
| Q99624086 | Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 |
| Q38869724 | Intracellular recycling and cross-presentation by MHC class I molecules. |
| Q38870485 | Investigational drugs in early development for treating dengue infection. |
| Q91891982 | Kinesin-1 regulates antigen cross-presentation through the scission of tubulations from early endosomes in dendritic cells |
| Q58862004 | Long-lasting cross-presentation of tumor antigen in human DC |
| Q37773241 | MUC1 immunotherapy. |
| Q77791988 | Metal nanomaterials: immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease |
| Q56209183 | Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis |
| Q37002001 | NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. |
| Q34007922 | New concepts in antimalarial use and mode of action in dermatology |
| Q90327245 | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| Q54207858 | Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection. |
| Q36484078 | Phagocytosis of picornavirus-infected cells induces an RNA-dependent antiviral state in human dendritic cells |
| Q98383361 | Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention |
| Q41911824 | Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer |
| Q36514286 | Presentation of phagocytosed antigens by MHC class I and II. |
| Q36933020 | Primary CD8+ T-cell response to soluble ovalbumin is improved by chloroquine treatment in vivo |
| Q40329387 | Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells |
| Q36945533 | Recent advances in antigen processing and presentation |
| Q36880738 | Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century |
| Q61807977 | Regulation of Antigen Export to the Cytosol During Cross-Presentation |
| Q47148814 | STIM1 promotes migration, phagosomal maturation and antigen cross-presentation in dendritic cells. |
| Q24652686 | Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset |
| Q39014554 | Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neu by human dendritic cells |
| Q28544964 | Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial |
| Q57616754 | Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells |
| Q35314263 | Studying the effect of chloroquine on sporozoite-induced protection and immune responses in Plasmodium berghei malaria |
| Q37371589 | Suicidal membrane repair regulates phosphatidylserine externalization during apoptosis |
| Q26746162 | Targeting dendritic cells: a promising strategy to improve vaccine effectiveness |
| Q39360987 | Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases |
| Q39104926 | The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules |
| Q95355800 | The Transcription Factor EB Links Cellular Stress to the Immune Response |
| Q38008353 | The ambiguity in immunology |
| Q37082455 | The cell biology of cross-presentation and the role of dendritic cell subsets |
| Q35913706 | The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice |
| Q98615844 | The host targeting effect of chloroquine in malaria |
| Q104517955 | The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens |
| Q37327058 | The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells |
| Q40883748 | The transcription factor TFEB acts as a molecular switch that regulates exogenous antigen-presentation pathways |
| Q47143389 | UNC93B1 interacts with the calcium sensor STIM1 for efficient antigen cross-presentation in dendritic cells. |
| Q38209325 | Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines |
| Q38208305 | Understanding the biology of antigen cross-presentation for the design of vaccines against cancer |
| Q33587443 | Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model |
| Q33703757 | pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides |
Search more.